The Bits in Bio Podcast podcast

Going Founder Mode on Cancer: Maximal Diagnostics, Personalized Therapies, and Patient-First Medicine with Sid Sijbrandij & Jacob Stern

0:00
43:47
Rewind 15 seconds
Fast Forward 15 seconds

Sid Sijbrandij, co-founder and Executive Chair of GitLab, and Jacob Stern, formerly of 10x Genomics, join us for our first-ever live episode to share how Sid went “founder mode” on his aggressive bone cancer after running out of standard treatment options.

We discuss the four principles behind their approach: maximal diagnostics, creating treatments, running treatments in parallel, and scaling for others. Jacob explains how single-cell sequencing guided an experimental radioligand therapy, and how a scan in Beijing reshaped a personalized cell therapy.

From publishing 25TB of Sid’s tumor data openly to launching twelve companies through Even One Ventures, Sid and Jacob share lessons on rescuing promising drugs, faster regulatory pathways, and making this approach accessible to everyone.

More episodes from "The Bits in Bio Podcast"